Investment Summary

Vespa Capital Invests In Fibrofind

On May 9, 2025, private equity firm Vespa Capital invested in life science company Fibrofind

Investment Highlights
  • This is Vespa Capital’s 2nd transaction in the Life Science sector.
  • This is Vespa Capital’s 21st transaction in the United Kingdom.

Investment Summary

Date 2025-05-09
Target Fibrofind
Sector Life Science
Investor(s) Vespa Capital
Deal Type Growth Capital
Advisor(s) Grant Thornton Transaction Advisory (Financial)
Mills & Reeve (Legal)

Target

Fibrofind

Newcastle upon Tyne, United Kingdom
Fibrofind is a pre-clinical contract research organisation, revolutionising drug testing and pre-clinical research. Fibrofind is based in Newcastle upon Tyne , United Kingdom.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Vespa Capital

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2007
PE ASSETS 330M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Vespa Capital is a private equity firm that targets minority or majority buyout investments in the UK. Vespa looks to partner with management when pursuing transactions and seeks opportunities valued from £10 to £70 million. The Firm prefers profitable, market leading businesses with strong growth prospects. Vespa is a generalist investor with no specific industry preferences.Vespa Capital is formed in 2007 and is based in London.


DEAL STATS #
Overall 24 of 24
Sector: Life Science M&A 2 of 2
Type: Growth Capital M&A Deals 12 of 12
Country: United Kingdom M&A 21 of 21
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-28 Rocksteady

Hampshire, United Kingdom

Rocksteady is a provider of progressive, inclusive, and empowering music education services to primary schools and children. Rocksteady is based in Hampshire, United Kingdom.

Buy -